Literature DB >> 28779708

E. coli O124 K72 alters the intestinal barrier and the tight junctions proteins of guinea pig intestine.

Xiaomeng Ren1, Yanyan Zhu2, Yaser Gamallat3, Shenhao Ma4, Gift Chiwala5, Abdo Meyiah6, Yi Xin7.   

Abstract

Our research group previously isolated and identified a strain of pathogenic Escherichia coli from clinical samples called E. coli O124 K72. The present study was aimed at determining the potential effects of E. coli O124 K72 on intestinal barrier functions and structural proteins integrity in guinea pig. Guinea pigs were grouped into three groups; control (CG); E. coli O124 K72 (E. coli); and probiotics Lactobacillus rhamnosus (LGG). Initially, we create intestinal dysbiosis by giving all animals Levofloxacin for 10days, but the control group (CG) received the same volume of saline. Then, the animals received either E. coli O124 K72 (E. coli) or Lactobacillus rhamnosus (LGG) according to their assigned group. E. coli O124 K72 treatment significantly affected colon morphology and distorted intestinal barrier function by up-regulating Claudin2 and down-regulating Occludin. In addition, E. coli upregulated the mRNA expression of MUC1, MUC2, MUC13 and MUC15. Furthermore, suspected tumor was found in the E. coli treated animals. Our results suggested that E. coli O124 K72 strain has adverse effects on intestinal barrier functions and is capable of altering integrity of structural proteins in guinea pig model while at same time it may have a role in colon carcinogenesis.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antibiotic; E. coli O124 K72; Intestinal barrier; Mucin

Mesh:

Substances:

Year:  2017        PMID: 28779708     DOI: 10.1016/j.biopha.2017.07.123

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  Infection with a human-derived enteroinvasive Escherichia coli strain altered intestinal barrier function in guinea pigs.

Authors:  Jian-Jun Liu; Juan-Juan Qiu; Xiu Shan; Xue-Qi Shang; Fu-Bo Sun; Ju-Ying Jiao; Ayaz Ahmed; Yi Xin; Dong Shang
Journal:  Int Microbiol       Date:  2022-06-20       Impact factor: 3.097

2.  Chitosan Ameliorates DSS-Induced Ulcerative Colitis Mice by Enhancing Intestinal Barrier Function and Improving Microflora.

Authors:  Jia Wang; Cuili Zhang; Chunmei Guo; Xinli Li
Journal:  Int J Mol Sci       Date:  2019-11-15       Impact factor: 5.923

Review 3.  Animal Models of Type III Secretion System-Mediated Pathogenesis.

Authors:  Julia A Hotinger; Aaron E May
Journal:  Pathogens       Date:  2019-11-22

4.  The in vitro Effects of the Probiotic Strain, Lactobacillus casei ZX633 on Gut Microbiota Composition in Infants With Diarrhea.

Authors:  Xing Wang; Miao Zhang; Weidong Wang; Haoxin Lv; Hua Zhang; Yuan Liu; Zhongfang Tan
Journal:  Front Cell Infect Microbiol       Date:  2020-09-10       Impact factor: 5.293

Review 5.  The Pivotal Role of Microbiota in Modulating the Neuronal-Glial-Epithelial Unit.

Authors:  Siyu Luo; Huifeng Zhu; Junhui Zhang; Dong Wan
Journal:  Infect Drug Resist       Date:  2021-12-21       Impact factor: 4.003

6.  Curcumin modulates gut microbiota and improves renal function in rats with uric acid nephropathy.

Authors:  Xueling Xu; Huifang Wang; Dandan Guo; Xiaofei Man; Jun Liu; Junying Li; Congjuan Luo; Ming Zhang; Li Zhen; Xuemei Liu
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

7.  Modulation of Gut Microbiota by Lactobacillus casei Fermented Raspberry Juice In Vitro and In Vivo.

Authors:  Ting Wu; Xueqi Chu; Yuxin Cheng; Shuxin Tang; Daniel Zogona; Siyi Pan; Xiaoyun Xu
Journal:  Foods       Date:  2021-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.